Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer’s perspective

Opportunities and challenges for commercializing microarray patches for vaccination from a MAP developer’s perspective

Continued advances in microarray patch (MAP) technology are starting to make needle-free delivery of a broad range of vaccines an achievable goal. The drivers and potential benefits of a MAP platform for pandemic response and routine vaccination are clear and include dose-sparing, cold-chain elimina...

Full description

Bibliographic Details
Main Authors: Angus Forster, Michael Junger
Format: Article
Language:English
Published: Taylor & Francis Group 2022-11-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
microarray patch
map
vaccine delivery
needle-free
pandemic preparedness
pandemic response
vaccine
influenza
Online Access:http://dx.doi.org/10.1080/21645515.2022.2050123

Internet

http://dx.doi.org/10.1080/21645515.2022.2050123

Similar Items